A Pharmacogenetics study of TPMT and ITPA genes detects relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine
Journal of Gastrointestinal and Liver Diseases. 2011;20:247-53.
Evaluation of adalimumab therapy in multidisciplinarystrategy for perianal Crohn’s disease patients withinfliximab failure
Journal of Crohn’s and Colitis 2010;4(3):654–660.
Clinical practice in Crohn’s disease in bordering regions of two countries:different medical options, distinct surgical events
Journal of Crohn’s and Colitis 2010;4(3):301-311.
Ulcerative colitis in the North of Portugal and Galicia in Spain
Inflammatory Bowel Disease 2010;16:1227-1238.
Long term (5 years) efficacy and safety OFO Infliximab in Crohn disease patients
R. Ferreiro, E. Fernandez-Salgado, V. Ollero, A. Lorenzo Gonzalez, D. Carpio, A. Echarri, A. Fernandez, L. De Castro, J.R. Pineda Marino, V. Hernandez, L. Sanromán, J. Martinez Cadilla, M.A. Pato, E. Santos, S. Pereira, J. Castro, M. Barreiro-de AcostaUEGW Estocolmo